Acclaro Medical | $23,000,000 | (May 30, 2025)
FarmQA, Inc | $4,000,000 | (May 30, 2025)
Uplinq | $10,000,000 | (May 30, 2025)
Predicta Biosciences
United States
- Cambridge, Massachusetts
- 17/07/2024
- Seed
- $5,200,000
Predicta Biosciences is a precision oncology company integrating cutting edge multiomics and liquid biopsies to develop innovative diagnostic and therapeutic products. Predicta's diagnostic product portfolio removes the burden of bone-marrow biopsies, through small blood-based samples, and enables best-in-class treatment decision-making for immunotherapies. Utilizing the data from the diagnostic platform, Predicta has an in-house therapeutic pipeline of novel immunotherapy targets in pre-clinical discovery and development.
- Industry Biotechnology Research
- Website https://www.predictabiosciences.com/
- LinkedIn https://www.linkedin.com/company/predicta-biosciences/
Related People
Kate (Gallagher) CavesFounder
United States -
Greater Boston
Executive Leader with Business Development, Corporate Development, Marketing and deep technical background in Therapeutic Development and Diagnostic tools. Passionate about the intersection of Biology, Healthcare, and AI.
KhiladiPro | $1,000,000 | (May 30, 2025)
LovOn | $850,000 | (May 30, 2025)
Volteras | $11,100,000 | (May 30, 2025)
ROXFIT | $1,077,281 | (May 30, 2025)
CurifyLabs | $7,594,115 | (May 30, 2025)
Outcomes4Me | $21,000,000 | (May 30, 2025)
Dream Park Immersive | $1,100,000 | (May 30, 2025)
Unbound(US) | $4,000,000 | (May 30, 2025)
Rime Labs | $5,500,000 | (May 30, 2025)
Vima Therapeutics | $60,000,000 | (May 30, 2025)